Stay updated on PEMBRACA: Pembrolizumab+Carboplatin in Breast Cancer Antigens Clinical Trial

Sign up to get notified when there's something new on the PEMBRACA: Pembrolizumab+Carboplatin in Breast Cancer Antigens Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PEMBRACA: Pembrolizumab+Carboplatin in Breast Cancer Antigens Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision: v3.3.4 has been added and replaces the previous revision, v3.3.3. This is an administrative update and does not alter study data or the information shown about the trial.
    Difference
    0.1%
    Check dated 2026-01-14T02:46:40.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Footer now displays 'Revision: v3.3.3'. The strings 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' are no longer present.
    Difference
    0.1%
    Check dated 2025-12-23T17:17:02.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2 with no observable changes to study content or layout; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T21:20:07.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Removed the government funding/operating status notice from the page. Core study details and eligibility criteria remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T18:36:06.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The new screenshot shows minor formatting and layout adjustments without altering essential study information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T13:22:40.000Z thumbnail image
  8. Check
    109 days ago
    Change Detected
    Summary
    Major update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.
    Difference
    4%
    Check dated 2025-10-06T04:13:44.000Z thumbnail image

Stay in the know with updates to PEMBRACA: Pembrolizumab+Carboplatin in Breast Cancer Antigens Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PEMBRACA: Pembrolizumab+Carboplatin in Breast Cancer Antigens Clinical Trial page.